Ochsner Health System And Select Medical Form Strategic Partnership And Announce New 60-Bed Hospital
Government Declines to Intervene in Action against Select Medical Corporation
Alnylam Reports New Positive Clinical Data for ALN-AT3, a Subcutaneously Administered, Investigational RNAi Therapeutic Targeting Antithrombin (AT) for the Treatment of Hemophilia and Rare Bleeding Disorders
Digital Social Retail based in New York (Group HOLOSFIND "ALHOL") announces the signature of an historic agreement
These managers have planned for the future—and protected strong records—by placing an emphasis on succession planning.
Call Tracking Leads to 60% Savings on Ad Spend for Retailers